A new class of highly effective weight loss medications could deal a blow to several major Swiss food companies while benefiting others, according to Vontobel. The drugs, which imitate the effects of the GLP-1 hormone to reduce appetite and calorie intake dramatically, are showing remarkable efficacy in clinical trials. As a result, patients lose up to 25% of their body weight on average.
"Companies exposed to the mentioned categories and present in high-obesity countries are more likely to see negative effects," the Vontobel analyst said. "Therefore, we see a medium impact" for both Swiss companies, Hasanaj added. Vontobel expects shares of Aryzta and Barry Callebaut to be relatively flat over the next 12 months. However, other analysts disagree. For instance, Stifel analyst Pascal Boll's bullish price targets point to a 37% upside potential for Aryzta.
Source: News Formal (newsformal.com)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Weight-Loss Drug Amycretin Has Patients Losing 13% of Body Weight in Just 3 MonthsDigital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Source: BestLifeOnline - 🏆 533. / 51 Read more »
Oprah slams body shaming: ‘Making fun of my weight was a national sport’Oprah Winfrey’s TV special explored the impact weight loss drugs are having on patients, while exploring her weight struggles and experience with weight-loss medication.
Source: washingtonpost - 🏆 95. / 72 Read more »
More teens are using weight loss drugs like Wegovy and OzempicMarina Kopf is an associate producer with the NBC News Health and Medical Unit.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss DrugsI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Source: Forbes - 🏆 394. / 53 Read more »
‘Pioneer Woman’ Ree Drummond 'did not take Ozempic' or other drugs for 50-pound weight lossFood Network star Ree Drummond updated a past blog post, where she shared how she lost over 50 pounds, noting that something she did not do was take weight-loss drugs like Ozempic.
Source: FoxNews - 🏆 9. / 87 Read more »
A faster, cheaper way to synthesize diabetes and weight loss drugs like semaglutideSemaglutide is part of the glucagon-like peptide-1 (GLP-1) receptor targeting family of peptide drugs which are mainly used to treat diabetes but are difficult and expensive to make.
Source: physorg_com - 🏆 388. / 55 Read more »